Contact

All Stories

  1. Acknowledgement to Reviewers

    Article • Neurology Open Access, June 2026, Wolters Kluwer Health

    Dr Fabricio Ferreira de Oliveira

  2. Fluid Biomarkers of Motor and Non-Motor Experiences of Daily Living in Dementia with Lewy Bodies and Alzheimer’s Disease

    Article • Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, March 2026, Cambridge University Press

    Dr Fabricio Ferreira de Oliveira, Professor Maria da Graça Naffah Mazzacoratti

  3. Acknowledgement to Reviewers

    Article • Case Reports in Neurology, December 2025, Karger Publishers

    Dr Fabricio Ferreira de Oliveira

  4. International consensus for the assessment of social cognition in neurocognitive disorders: framework definition and clinical recommendations of the SIGNATURE initiative

    Article • Alzheimer s Research & Therapy, December 2025, Springer Science + Business Media

    Dr Fabricio Ferreira de Oliveira, Dr Agustin Ibanez

  5. Omics-AD—A multimodal biomarker study on cognitive decline and neuropsychiatric symptoms: Design and cohort characteristics

    Article • Journal of Alzheimer’s Disease, December 2025, SAGE Publications

    Dr Fabricio Ferreira de Oliveira

  6. The measurement of agitation in neurocognitive disorders: A systematic review

    Article • Alzheimer s & Dementia, December 2025, Wiley

    Dr Fabricio Ferreira de Oliveira

  7. Plasma biomarkers in neuropsychiatric syndromes: A narrative review

    Article • Journal of Alzheimer’s Disease, November 2025, SAGE Publications

    Dr Fabricio Ferreira de Oliveira

  8. Disentangling the Clinical and Neuroimaging Spectrum of Neuronal α-Synucleinopathies

    Article • Neurology, November 2025, Wolters Kluwer Health

    Dr Fabricio Ferreira de Oliveira

  9. Acknowledgement to Reviewers

    Article • European Neurology, November 2025, Karger Publishers

    Dr Fabricio Ferreira de Oliveira

  10. List of reviewers

    Article • Journal of Alzheimer’s Disease, October 2025, SAGE Publications

    Dr Fabricio Ferreira de Oliveira

  11. Atrophy patterns of deep gray matter nuclei in Alzheimer's disease and frontotemporal dementia

    Article • Journal of Alzheimer’s Disease, October 2025, SAGE Publications

    Dr Fabricio Ferreira de Oliveira

  12. The relationships between cerebrospinal fluid neurofilament light chain and hippocampal atrophy with cognitive decline

    Article • Journal of Alzheimer’s Disease, August 2025, SAGE Publications

    Dr Fabricio Ferreira de Oliveira

  13. Leveraging multiomic approaches to elucidate mechanisms of heterogeneity in Alzheimer's disease: Neuropsychiatric symptoms, co‐pathologies, and sex differences

    Article • Alzheimer s & Dementia, August 2025, Wiley

    Dr Fabricio Ferreira de Oliveira

  14. Message From the Editors to Our Reviewers

    Article • Neurology, July 2025, Wolters Kluwer Health

    Dr Fabricio Ferreira de Oliveira

  15. International consensus for the assessment of social cognition in neurocognitive disorders: framework definition and clinical recommendations of the SIGNATURE initiative

    Article • June 2025, Springer Science + Business Media

    Dr Fabricio Ferreira de Oliveira

  16. APOE -mediated associations of promoter variants of GRIN1 and GRIN2B with behavioral symptoms and age at onset of Alzheimer’s disease dementia

    Article • Neurological Research, May 2025, Taylor & Francis

    Dr Fabricio Ferreira de Oliveira

  17. Understanding barriers and optimizing socio‐cognitive assessment in the diagnosis of neurocognitive disorders

    Article • Journal of Neuropsychology, May 2025, Wiley

    Dr Fabricio Ferreira de Oliveira, Dr Agustin Ibanez

  18. Analysis and interpretation of inflammatory fluid markers in Alzheimer’s disease: a roadmap for standardization

    Article • Journal of Neuroinflammation, April 2025, Springer Science + Business Media

    Dr Fabricio Ferreira de Oliveira

  19. Message From the Editors to Our Reviewers

    Article • Neurology, January 2025, Wolters Kluwer Health

    Dr Fabricio Ferreira de Oliveira

  20. The problem of multiple adjustments in the assessment of minimal clinically important differences

    Article • Alzheimer s & Dementia Translational Research & Clinical Interventions, January 2025, Wiley

    Dr Fabricio Ferreira de Oliveira

  21. Biomarkers in Clinical Trials of Alzheimer Disease: An Overview

    Article • January 2025, Springer Science + Business Media

    Dr Fabricio Ferreira de Oliveira

  22. Associations between selected genetic variants and lipid profile variability in response to statins in Alzheimer’s disease: a prospective observational study

    Article • Sao Paulo Medical Journal, January 2025, FapUNIFESP (SciELO)

    Dr Fabricio Ferreira de Oliveira

  23. List of Reviewers

    Article • Journal of Alzheimer’s Disease, December 2024, SAGE Publications

    Dr Fabricio Ferreira de Oliveira

  24. Anthropometric and Demographic Features Affect the Interpretation of Cerebrospinal Fluid Biomarkers in Patients with Different Dementia Syndromes and Cognitively Healthy Adults

    Article • November 2024, Springer Science + Business Media

    Dr Fabricio Ferreira de Oliveira, Professor Maria da Graça Naffah Mazzacoratti

  25. Considerations for widespread implementation of blood‐based biomarkers of Alzheimer's disease

    Article • Alzheimer s & Dementia, October 2024, Wiley

    Dr Fabricio Ferreira de Oliveira

  26. Recommendations for clinical implementation of blood‐based biomarkers for Alzheimer's disease

    Article • Alzheimer s & Dementia, October 2024, Wiley

    Dr Fabricio Ferreira de Oliveira

  27. Assessing Independence in Activities of Daily Living and Quality of Life in Patients with Dementia with Lewy Bodies

    Article • Journal of Alzheimer’s Disease, August 2024, IOS Press

    Dr Fabricio Ferreira de Oliveira

  28. Message From the Editors to Our Reviewers

    Article • Neurology, July 2024, Wolters Kluwer Health

    Dr Fabricio Ferreira de Oliveira

  29. Shedding Light on the Effects of Blood Pressure on Cognitive Decline and Dementia Risk by Way of Neurobiological Evidence

    Article • Journal of Alzheimer’s Disease, April 2024, IOS Press

    Dr Fabricio Ferreira de Oliveira

  30. Biofluid Activity and Levels of the Angiotensin-converting Enzyme Are Surrogates for Diverse Cerebrospinal Fluid Amyloid-beta Effects in Dementia with Lewy Bodies and Alzheimer’s Dementia (P6-9.001)

    Article • Neurology, April 2024, Wolters Kluwer Health

    Dr Fabricio Ferreira de Oliveira, Professor Maria da Graça Naffah Mazzacoratti

  31. Message From the Editors to Our Reviewers

    Article • Neurology, January 2024, Wolters Kluwer Health

    Dr Fabricio Ferreira de Oliveira

  32. Acknowledgement to Reviewers

    Article • Case Reports in Neurology, December 2023, Karger Publishers

    Dr Fabricio Ferreira de Oliveira

  33. List of Reviewers

    Article • Journal of Alzheimer’s Disease, December 2023, IOS Press

    Dr Fabricio Ferreira de Oliveira

  34. GRIN2B genotypes and APOE haplotypes affect the age at onset of Alzheimer’s dementia as well as variations in dementia staging according to the use of Memantine

    Article • Alzheimer s & Dementia, December 2023, Wiley

    Dr Fabricio Ferreira de Oliveira

  35. Differential performance of cerebrospinal fluid biomarker ratios and formulas to discriminate dementia with Lewy bodies from Alzheimer’s dementia and cognitively healthy people reflects high level of amyloidosis across dementia syndromes

    Article • Alzheimer s & Dementia, December 2023, Wiley

    Dr Fabricio Ferreira de Oliveira, Professor Maria da Graça Naffah Mazzacoratti

  36. Biofluid activity and levels of the angiotensin‐converting enzyme may translate into distinct neuropsychiatric symptoms associated with cerebrospinal fluid amyloid‐beta effects and tauopathy in dementia with Lewy bodies and Alzheimer’s dementia

    Article • Alzheimer s & Dementia, December 2023, Wiley

    Dr Fabricio Ferreira de Oliveira, Professor Maria da Graça Naffah Mazzacoratti

  37. Disparities in neuropsychiatric symptom clusters across dementia diagnoses within Lewy body dementia syndromes and Alzheimer’s dementia

    Article • Alzheimer s & Dementia, December 2023, Wiley

    Dr Fabricio Ferreira de Oliveira, Professor Maria da Graça Naffah Mazzacoratti

  38. Variations in metabolic risk factors for dementia do not affect APOE‐mediated cognitive or functional decline in patients with Alzheimer’s disease from São Paulo, Brazil

    Article • Alzheimer s & Dementia, December 2023, Wiley

    Dr Fabricio Ferreira de Oliveira

  39. Pitfalls and biases in neuroepidemiological studies of COVID-19 and the nervous system: a critical appraisal of the current evidence and future directions

    Article • Deutsche Zeitschrift für Nervenheilkunde, September 2023, Springer Science + Business Media

    Dr Fabricio Ferreira de Oliveira

  40. Pharmacogenetics of angiotensin modulators according to APOE-ε4 alleles and the ACE insertion/deletion polymorphism in Alzheimer’s disease

    Article • Acta Neuropsychiatrica, August 2023, Cambridge University Press

    Dr Fabricio Ferreira de Oliveira

  41. Message From the Editors to Our Reviewers

    Article • Neurology, July 2023, Wolters Kluwer Health

    Dr Fabricio Ferreira de Oliveira

  42. Looking Behind the Curtain: Patient Stratification According to Genetic or Demographic Factors May Yield Unexpected Results in Studies of Neurodegenerative Diseases

    Article • Journal of Alzheimer’s Disease, June 2023, IOS Press

    Dr Fabricio Ferreira de Oliveira

  43. Effects of the DICE Method to Improve Timely Recognition and Treatment of Neuropsychiatric Symptoms in Early Alzheimer’s Disease at the Memory Clinic: The BEAT-IT Study

    Article • Journal of Alzheimer’s Disease, June 2023, IOS Press

    Dr Fabricio Ferreira de Oliveira

  44. Differential associations of clinical features with cerebrospinal fluid biomarkers in dementia with Lewy bodies and Alzheimer’s disease

    Article • Aging Clinical and Experimental Research, June 2023, Springer Science + Business Media

    Dr Fabricio Ferreira de Oliveira, Professor Maria da Graça Naffah Mazzacoratti

  45. Lifestyle and pharmacological interventions in South America: Potential barriers for recruitment, implementation, and effectiveness

    Article • Alzheimer s & Dementia, June 2023, Wiley

    Dr Fabricio Ferreira de Oliveira, Professor Maria da Graça Naffah Mazzacoratti

  46. Acknowledgement to Reviewers

    Article • Dementia and Geriatric Cognitive Disorders, January 2023, Karger Publishers

    Dr Fabricio Ferreira de Oliveira

  47. Message From the Editors to Our Reviewers

    Article • Neurology, December 2022, Wolters Kluwer Health

    Dr Fabricio Ferreira de Oliveira

  48. List of Reviewers

    Article • Journal of Alzheimer’s Disease, December 2022, IOS Press

    Dr Fabricio Ferreira de Oliveira

  49. The Advisory Group on Risk Evidence Education for Dementia: Multidisciplinary and Open to All

    Article • Journal of Alzheimer’s Disease, November 2022, IOS Press

    Dr Fabricio Ferreira de Oliveira

  50. Acknowledgement to Referees

    Article • CNS Drugs, November 2022, Springer Science + Business Media

    Dr Fabricio Ferreira de Oliveira

  51. Acknowledgement

    Article • Psychogeriatrics, November 2022, Wiley

    Dr Fabricio Ferreira de Oliveira

  52. APOE ε4 Carrier Status as Mediator of Effects of Psychotropic Drugs on Clinical Changes in Patients With Alzheimer’s Disease

    Article • Journal of Neuropsychiatry, October 2022, American Psychiatric Association

    Dr Fabricio Ferreira de Oliveira

  53. Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions

    Article • Journal of Alzheimer’s Disease, August 2022, IOS Press

    Dr Fabricio Ferreira de Oliveira, Dr Luis F Agüera-Ortiz

  54. Message From the Editors to Our Reviewers

    Article • Neurology, July 2022, Wolters Kluwer Health

    Dr Fabricio Ferreira de Oliveira

  55. Pharmacogenetic Analyses of Therapeutic Effects of Lipophilic Statins on Cognitive and Functional Changes in Alzheimer’s Disease

    Article • Journal of Alzheimer’s Disease, May 2022, IOS Press

    Dr Fabricio Ferreira de Oliveira

  56. New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia

    Article • Alzheimer s & Dementia, March 2022, Wiley

    Dr Fabricio Ferreira de Oliveira

  57. The Viability of Treatment Conditioned to the Pathophysiology of Alzheimer’s Disease

    Article • January 2022, Springer Science + Business Media

    Dr Fabricio Ferreira de Oliveira

  58. Vascular cognitive impairment and dementia: An early career researcher perspective

    Article • Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring, January 2022, Wiley

    Dr Fabricio Ferreira de Oliveira, Dr Atticus H Hainsworth

  59. Message From the Editors to Our Reviewers

    Article • Neurology, December 2021, Wolters Kluwer Health

    Dr Fabricio Ferreira de Oliveira

  60. List of Reviewers

    Article • Journal of Alzheimer’s Disease, December 2021, IOS Press

    Dr Fabricio Ferreira de Oliveira

  61. Acknowledgement

    Article • Psychogeriatrics, November 2021, Wiley

    Dr Fabricio Ferreira de Oliveira

  62. Reviewer Acknowledgement, 2021

    Article • PSU Medical Journal, September 2021, Faculty of Medicine Prince of Songkla University

    Dr Fabricio Ferreira de Oliveira

  63. Message From the Editors to Our Reviewers

    Article • Neurology, July 2021, Wolters Kluwer Health

    Dr Fabricio Ferreira de Oliveira

  64. Associations of Neuropsychiatric Features with Cerebrospinal Fluid Biomarkers of Amyloidogenesis and Neurodegeneration in Dementia with Lewy Bodies Compared with Alzheimer’s Disease and Cognitively Healthy People

    Article • Journal of Alzheimer’s Disease, June 2021, IOS Press

    Dr Fabricio Ferreira de Oliveira, Professor Maria da Graça Naffah Mazzacoratti

  65. Abstract Anne H Berman – incoming ISBM president

    Article • International Journal of Behavioral Medicine, June 2021, Springer Science + Business Media

    Dr Fabricio Ferreira de Oliveira, Frank Sullivan, Professor Keith A Bender

  66. Behavioural effects of the ACE insertion/deletion polymorphism in Alzheimer’s disease depend upon stratification according to APOE-ϵ4 carrier status

    Article • Cognitive Neuropsychiatry, May 2021, Taylor & Francis

    Dr Fabricio Ferreira de Oliveira

  67. Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe

    Article • Alzheimer s & Dementia, May 2021, Wiley

    Dr Fabricio Ferreira de Oliveira

  68. APOE-ɛ4-mediated correlates of cerebrospinal fluid biomarkers of amyloidosis and neurodegeneration with cognition and functionality in dementia with Lewy bodies compared with Alzheimer’s dementia and cognitively healthy people (49)

    Article • Neurology, April 2021, Wolters Kluwer Health

    Dr Fabricio Ferreira de Oliveira, Professor Maria da Graça Naffah Mazzacoratti

  69. Acknowledgements to Reviewers

    Article • Current Alzheimer Research, March 2021, Bentham Science Publishers

    Dr Fabricio Ferreira de Oliveira

  70. Swallowing in behavioral variant frontotemporal dementia

    Article • Arquivos de Neuro-Psiquiatria, January 2021, FapUNIFESP (SciELO)

    Dr Fabricio Ferreira de Oliveira

  71. Message From the Editors to Our Reviewers

    Article • Neurology, December 2020, Wolters Kluwer Health

    Dr Fabricio Ferreira de Oliveira

  72. List of Reviewers

    Article • Journal of Alzheimer’s Disease, December 2020, IOS Press

    Dr Fabricio Ferreira de Oliveira

  73. Klüver‐Bucy syndrome due to stroke in the left temporal lobe

    Article • Alzheimer s & Dementia, December 2020, Wiley

    Dr Fabricio Ferreira de Oliveira

  74. Vascular cognitive impairment due to dilated perivascular spaces in putamen: Connections with the ventrolateral prefrontal cortex and neurological deficits

    Article • Alzheimer s & Dementia, December 2020, Wiley

    Dr Fabricio Ferreira de Oliveira

  75. Dementia in Latin America: Paving the way toward a regional action plan

    Article • Alzheimer s & Dementia, November 2020, Wiley

    Dr Fabricio Ferreira de Oliveira, Adolfo M. García, Dr Agustin Ibanez, Sergio Ferreira, Dominic Trépel

  76. Correlates of neuropsychiatric and motor tests with language assessment in patients with Lewy body dementia

    Article • Archives of Clinical Psychiatry (São Paulo), June 2020, FapUNIFESP (SciELO)

    Dr Fabricio Ferreira de Oliveira

  77. Selected LDLR and APOE Polymorphisms Affect Cognitive and Functional Response to Lipophilic Statins in Alzheimer’s Disease

    Article • Journal of Molecular Neuroscience, May 2020, Springer Science + Business Media

    Dr Fabricio Ferreira de Oliveira

  78. Neuropsychiatric feature profiles of patients with Lewy body dementia

    Article • Clinical Neurology and Neurosurgery, April 2020, Elsevier

    Dr Fabricio Ferreira de Oliveira, Professor Maria da Graça Naffah Mazzacoratti

  79. Agitation and impulsivity in mid and late life as possible risk markers for incident dementia

    Article • Alzheimer s & Dementia Translational Research & Clinical Interventions, January 2020, Wiley

    Dr Fabricio Ferreira de Oliveira

  80. The impact of SARS‐CoV‐2 in dementia across Latin America: A call for an urgent regional plan and coordinated response

    Article • Alzheimer s & Dementia Translational Research & Clinical Interventions, January 2020, Wiley

    Dr Fabricio Ferreira de Oliveira, Dr Agustin Ibanez, Dominic Trépel

  81. Acknowledgments

    Article • Psychogeriatrics, November 2019, Wiley

    Dr Fabricio Ferreira de Oliveira

  82. CEREBROSPINAL-FLUID-BASED BIOMARKER EVIDENCE OF AMYLOIDOGENESIS IN DEMENTIA WITH LEWY BODIES DEPENDS UPON APOE-ε4 CARRIER STATUS

    Article • Alzheimer s & Dementia, July 2019, Elsevier

    Dr Fabricio Ferreira de Oliveira, Professor Maria da Graça Naffah Mazzacoratti

  83. PRISON WITHOUT WALLS: A CASE REPORT OF SEMANTIC VARIANT PRIMARY PROGRESSIVE APHASIA

    Article • Alzheimer s & Dementia, July 2019, Elsevier

    Dr Fabricio Ferreira de Oliveira

  84. GRIN2A GENOTYPES AND APOE HAPLOTYPES AFFECT THE AGE AT ONSET OF ALZHEIMER’S DEMENTIA BUT NOT FUNCTIONAL OR COGNITIVE RESPONSE TO MEMANTINE

    Article • Alzheimer s & Dementia, July 2019, Elsevier

    Dr Fabricio Ferreira de Oliveira

  85. FOOT CLEARANCE WHILE STEPPING-IN-PLACE AS A TOOL TO SALIENT COGNITIVE AND MOTOR OUTPUT DEFICITS IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT: A PRELIMINARY STUDY

    Article • Alzheimer s & Dementia, July 2019, Elsevier

    Dr Fabricio Ferreira de Oliveira

  86. BEHAVIORAL CORRELATES OF CEREBROSPINAL FLUID BIOMARKERS ACCORDING TO APOE-ε4 CARRIER STATUS IN DEMENTIA WITH LEWY BODIES COMPARED WITH ALZHEIMER’S DEMENTIA AND COGNITIVELY HEALTHY PEOPLE

    Article • Alzheimer s & Dementia, July 2019, Elsevier

    Dr Fabricio Ferreira de Oliveira, Professor Maria da Graça Naffah Mazzacoratti

  87. Pharmacogenetic analyses of variations of measures of cardiovascular risk in Alzheimer's dementia

    Article • International Journal of Microbiology Research, January 2019, Medknow

    Dr Fabricio Ferreira de Oliveira

  88. Acknowledgements to Reviewers

    Article • Current Alzheimer Research, November 2018, Bentham Science Publishers

    Dr Fabricio Ferreira de Oliveira

  89. Acknowledgments

    Article • Psychogeriatrics, November 2018, Wiley

    Dr Fabricio Ferreira de Oliveira

  90. Influence of Socioeconomic Status and Stress Over Quality of Sleep: A Systematic Review

    Article • October 2018, MDPI AG

    Dr Fabricio Ferreira de Oliveira

  91. Author Index

    Article • Movement Disorders, October 2018, Wiley

    Dr Fabricio Ferreira de Oliveira

  92. Keyword Index

    Article • Movement Disorders, October 2018, Wiley

    Dr Fabricio Ferreira de Oliveira

  93. Movement Disorders: Volume 33, Number S2, October 2018

    Article • Movement Disorders, October 2018, Wiley

    Dr Fabricio Ferreira de Oliveira

  94. Abstracts

    Article • Movement Disorders, October 2018, Wiley

    Dr Fabricio Ferreira de Oliveira, Adj Prof Laurent Alain Frossard

  95. Lifetime Risk Factors for Functional and Cognitive Outcomes in Patients with Alzheimer’s Disease

    Article • Journal of Alzheimer’s Disease, August 2018, IOS Press

    Dr Fabricio Ferreira de Oliveira, Professor Maria da Graça Naffah Mazzacoratti

  96. GENETICALLY MEDIATED LIFETIME RISK FACTORS FOR COGNITIVE AND FUNCTIONAL DECLINE IN PATIENTS WITH ALZHEIMER’S DEMENTIA FROM SÃO PAULO, BRAZIL

    Article • Alzheimer s & Dementia, July 2018, Elsevier

    Dr Fabricio Ferreira de Oliveira, Professor Maria da Graça Naffah Mazzacoratti

  97. APOE-DEPENDENT PSYCHOTROPIC EFFECTS OVER CLINICAL CHANGES IN ALZHEIMER’S DISEASE DEMENTIA

    Article • Alzheimer s & Dementia, July 2018, Elsevier

    Dr Fabricio Ferreira de Oliveira

  98. COGNITIVE AND FUNCTIONAL CORRELATES OF CEREBROSPINAL FLUID CONCENTRATIONS OF AMINOACIDS AND MONOAMINE METABOLITES ACCORDING TO APOE-ε4 CARRIER STATUS IN DEMENTIA WITH LEWY BODIES COMPARED WITH ALZHEIMER’S DEMENTIA AND COGNITIVELY HEALTHY PEOPLE

    Article • Alzheimer s & Dementia, July 2018, Elsevier

    Dr Fabricio Ferreira de Oliveira, Professor Maria da Graça Naffah Mazzacoratti

  99. COGNITIVE CHANGES ARE PHARMACOGENETICALLY MEDIATED BY ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN PATIENTS WITH ALZHEIMER’S DISEASE DEMENTIA

    Article • Alzheimer s & Dementia, July 2018, Elsevier

    Dr Fabricio Ferreira de Oliveira

  100. Behavioral correlates of cerebrospinal fluid concentrations of aminoacids and monoamine metabolites according to APOE-ɛ4 carrier status in dementia with Lewy bodies compared with Alzheimer’s dementia and cognitively healthy people (P4.190)

    Article • Neurology, April 2018, Wolters Kluwer Health

    Dr Fabricio Ferreira de Oliveira, Professor Maria da Graça Naffah Mazzacoratti

  101. Pharmacogenetics of Angiotensin-Converting Enzyme Inhibitors in Patients with Alzheimer's Disease Dementia

    Article • Current Alzheimer Research, February 2018, Bentham Science Publishers

    Dr Fabricio Ferreira de Oliveira, MARILIA A C SMITH, Paulo Bertolucci

  102. Acknowledgement to reviewers

    Article • Brain Injury, November 2017, Taylor & Francis

    Dr Fabricio Ferreira de Oliveira

  103. Effects of APOE haplotypes and measures of cardiovascular risk over gender-dependent cognitive and functional changes in one year in Alzheimer's disease

    Article • International Journal of Neuroscience, November 2017, Taylor & Francis

    Dr Fabricio Ferreira de Oliveira

  104. Acknowledgements to Reviewers

    Article • Current Alzheimer Research, October 2017, Bentham Science Publishers

    Dr Fabricio Ferreira de Oliveira

  105. ePresentation

    Article • European Journal of Neurology, July 2017, Wiley

    Dr Fabricio Ferreira de Oliveira

  106. ePoster Session

    Article • European Journal of Neurology, July 2017, Wiley

    Dr Fabricio Ferreira de Oliveira

  107. Author Index

    Article • European Journal of Neurology, July 2017, Wiley

    Dr Fabricio Ferreira de Oliveira

  108. Issue Information

    Article • European Journal of Neurology, July 2017, Wiley

    Dr Fabricio Ferreira de Oliveira

  109. Associations of cerebrovascular metabolism genotypes with neuropsychiatric symptoms and age at onset of Alzheimer’s disease dementia

    Article • Brazilian Journal of Psychiatry, June 2017, FapUNIFESP (SciELO)

    Dr Fabricio Ferreira de Oliveira

  110. Longitudinal lipid profile variations and clinical change in Alzheimer's disease dementia

    Article • Neuroscience Letters, April 2017, Elsevier

    Dr Fabricio Ferreira de Oliveira

  111. Reviewers for International Journal of Stroke 2016

    Article • International Journal of Stroke, February 2017, SAGE Publications

    Dr Fabricio Ferreira de Oliveira

  112. Neurological impressions on the organization of language networks in the human brain

    Article • Brain Injury, October 2016, Taylor & Francis

    Dr Fabricio Ferreira de Oliveira

  113. GRIN1 GENOTYPES AND APOE GENE HAPLOTYPES AFFECT THE AGE AT ONSET OF ALZHEIMER'S DISEASE DEMENTIA BUT NOT COGNITIVE OR FUNCTIONAL RESPONSE TO MEMANTINE

    Article • Alzheimer s & Dementia, July 2016, Elsevier

    Dr Fabricio Ferreira de Oliveira

  114. EFFECTS OF APOE GENE HAPLOTYPES AND MEASURES OF CARDIOVASCULAR RISK OVER COGNITIVE AND FUNCTIONAL DECLINE IN ONE YEAR IN PATIENTS WITH ALZHEIMER'S DISEASE DEMENTIA

    Article • Alzheimer s & Dementia, July 2016, Elsevier

    Dr Fabricio Ferreira de Oliveira

  115. MOTOR ASPECTS OF DAILY LIVING FOLLOW COGNITIVE AND FUNCTIONAL STATUS BUT NOT BEHAVIOURAL SYMPTOMS IN PATIENTS WITH LEWY BODY DEMENTIA SYNDROMES

    Article • Alzheimer s & Dementia, July 2016, Elsevier

    Dr Fabricio Ferreira de Oliveira, Professor Maria da Graça Naffah Mazzacoratti

  116. Balance impairment does not necessarily coexist with gait apraxia in mild and moderate Alzheimer’s disease

    Article • Arquivos de Neuro-Psiquiatria, June 2016, FapUNIFESP (SciELO)

    Dr Fabricio Ferreira de Oliveira

  117. Pharmacogenetic effects of angiotensin-converting enzyme inhibitors over age-related urea and creatinine variations in patients with dementia due to Alzheimer disease

    Article • Colombia Medica, June 2016, Universidad del Valle

    Dr Fabricio Ferreira de Oliveira

  118. Swallowing in primary progressive aphasia

    Article • NeuroRehabilitation, February 2016, IOS Press

    Dr Fabricio Ferreira de Oliveira, Sheilla de Medeiros Correia Marin

  119. Predictors of Cognitive and Functional Decline in Patients With Alzheimer Disease Dementia From Brazil

    Article • Alzheimer Disease & Associated Disorders, January 2016, Wolters Kluwer Health

    Dr Fabricio Ferreira de Oliveira

  120. Associations of Blood Pressure with Functional and Cognitive Changes in Patients with Alzheimer's Disease

    Article • Dementia and Geriatric Cognitive Disorders, January 2016, Karger Publishers

    Dr Fabricio Ferreira de Oliveira

  121. The Controversial Influence of Cerebrovascular Risk Factors over Pathological Mechanisms of Late-Onset Alzheimer's Disease Dementia

    Article • December 2015, Bio Accent Group LLC

    Dr Fabricio Ferreira de Oliveira

  122. Risk factors for cognitive and functional change in one year in patients with Alzheimer's disease dementia from São Paulo, Brazil

    Article • Journal of the Neurological Sciences, December 2015, Elsevier

    Dr Fabricio Ferreira de Oliveira

  123. Correlations among cognitive and behavioural assessments in patients with dementia due to Alzheimer's disease

    Article • Clinical Neurology and Neurosurgery, August 2015, Elsevier

    Dr Fabricio Ferreira de Oliveira

  124. Contrasts Between Patients With Lewy Body Dementia Syndromes and APOE-ε3/ε3 Patients With Late-onset Alzheimer Disease Dementia

    Article • The Neurologist, August 2015, Wolters Kluwer Health

    Dr Fabricio Ferreira de Oliveira, Sheilla de Medeiros Correia Marin

  125. A patient with agrammatic primary progressive aphasia developing frontotemporal dementia

    Article • Acta Neurologica Belgica, March 2015, Springer Science + Business Media

    Dr Fabricio Ferreira de Oliveira

  126. Pharmacogenetics of cerebrovascular metabolism modulators in dementia due to Alzheimer’s disease

    Article • Arquivos de Neuro-Psiquiatria, March 2015, FapUNIFESP (SciELO)

    Dr Fabricio Ferreira de Oliveira

  127. Assessment of sleep satisfaction in patients with dementia due to Alzheimer’s disease

    Article • Journal of Clinical Neuroscience, December 2014, Elsevier

    Dr Fabricio Ferreira de Oliveira

  128. Acknowledgements

    Article • Brain Injury, November 2014, Taylor & Francis

    Dr Fabricio Ferreira de Oliveira

  129. Is there correlation between cognition and functionality in severe dementia? The value of a performance-based ecological assessment for Alzheimer’s disease

    Article • Arquivos de Neuro-Psiquiatria, November 2014, FapUNIFESP (SciELO)

    Dr Fabricio Ferreira de Oliveira, Sheilla de Medeiros Correia Marin

  130. Brain-Penetrating Angiotensin-Converting Enzyme Inhibitors and Cognitive Change in Patients with Dementia due to Alzheimer's Disease

    Article • Journal of Alzheimer’s Disease, September 2014, IOS Press

    Dr Fabricio Ferreira de Oliveira

  131. P2‐024: PHARMACOGENETICS OF BRAIN‐PENETRATING ANGIOTENSIN‐CONVERTING ENZYME INHIBITORS IN DEMENTIA DUE TO ALZHEIMER'S DISEASE

    Article • Alzheimer s & Dementia, July 2014, Wiley

    Dr Fabricio Ferreira de Oliveira

  132. P2‐025: PHARMACOGENETICS OF CHOLESTEROL‐LOWERING DRUGS IN PATIENTS WITH DEMENTIA DUE TO ALZHEIMER'S DISEASE

    Article • Alzheimer s & Dementia, July 2014, Wiley

    Dr Fabricio Ferreira de Oliveira

  133. P3‐333: RISK FACTORS FOR COGNITIVE CHANGE IN PATIENTS WITH DEMENTIA DUE TO ALZHEIMER'S DISEASE FROM SÃO PAULO, BRAZIL

    Article • Alzheimer s & Dementia, July 2014, Wiley

    Dr Fabricio Ferreira de Oliveira

  134. Caregiver awareness of cerebrovascular risk of patients with dementia due to Alzheimer's disease in São Paulo, Brazil

    Article • Archives of Clinical Psychiatry (São Paulo), July 2014, FapUNIFESP (SciELO)

    Dr Fabricio Ferreira de Oliveira

  135. Abstracts from the 29th CINP World Congress of Neuropsychopharmacology, Vancouver, Canada, 22–26 June 2014

    Article • The International Journal of Neuropsychopharmacology, June 2014, Oxford University Press (OUP)

    Dr Fabricio Ferreira de Oliveira, Cecilie Bay-Richter

  136. Risk Factors for Cognitive Change in Patients with Dementia Due to Alzheimer’s Disease (P5.210)

    Article • Neurology, April 2014, Wolters Kluwer Health

    Dr Fabricio Ferreira de Oliveira

  137. Pharmacogenetics of Lipid Metabolism Modulators in Patients with Dementia Due to Alzheimer’s Disease (P5.223)

    Article • Neurology, April 2014, Wolters Kluwer Health

    Dr Fabricio Ferreira de Oliveira

  138. Risk factors for age at onset of dementia due to Alzheimer's disease in a sample of patients with low mean schooling from São Paulo, Brazil

    Article • International Journal of Geriatric Psychiatry, March 2014, Wiley

    Dr Fabricio Ferreira de Oliveira

  139. 2013 Reviewer Acknowledgement

    Article • Brain Injury, February 2014, Taylor & Francis

    Dr Fabricio Ferreira de Oliveira

  140. Assessment of risk factors for earlier onset of sporadic Alzheimer′s disease dementia

    Article • Neurology India, January 2014, Medknow

    Dr Fabricio Ferreira de Oliveira

  141. Educational bias in the assessment of severe dementia: Brazilian cutoffs for severe Mini-Mental State Examination

    Article • Arquivos de Neuro-Psiquiatria, January 2014, FapUNIFESP (SciELO)

    Dr Fabricio Ferreira de Oliveira, Sheilla de Medeiros Correia Marin

  142. Pharmacological modulation of cognitive and behavioral symptoms in patients with dementia due to Alzheimer's disease

    Article • Journal of the Neurological Sciences, January 2014, Elsevier

    Dr Fabricio Ferreira de Oliveira

  143. Cognitive Impairment in Fibromyalgia

    Article • Current Review of Pain, May 2013, Springer Science + Business Media

    Dr Fabricio Ferreira de Oliveira

  144. Impact of Cardiovascular Risk over the Rate of Progression of Dementia Due to Alzheimer's Disease in a Sample of Patients with Low Schooling from São Paulo, Brazil (IN6-1.009)

    Article • Neurology, February 2013, Wolters Kluwer Health

    Dr Fabricio Ferreira de Oliveira

  145. Impact of Cardiovascular Risk over the Rate of Progression of Dementia Due to Alzheimer's Disease in a Sample of Patients with Low Schooling from São Paulo, Brazil (P07.136)

    Article • Neurology, February 2013, Wolters Kluwer Health

    Dr Fabricio Ferreira de Oliveira

  146. Communicating with the non-dominant hemisphere: Implications for neurological rehabilitation

    Article • Neural Regeneration Research, January 2013, Medknow

    Dr Fabricio Ferreira de Oliveira

  147. Normal pressure hydrocephalus in the spectrum of neurological complications of systemic lupus erythematosus

    Article • Neurological Sciences, July 2012, Springer Science + Business Media

    Dr Fabricio Ferreira de Oliveira

  148. A patient with primary progressive aphasia developing dementia due to Alzheimer's disease

    Article • Arquivos de Neuro-Psiquiatria, July 2012, FapUNIFESP (SciELO)

    Dr Fabricio Ferreira de Oliveira

  149. Impact of Cerebrovascular Risk Factors over Age of Onset of Dementia Due to Alzheimer's Disease in a Sample of Patients with Low Schooling from Sao Paulo, Brazil (P04.201)

    Article • Neurology, April 2012, Wolters Kluwer Health

    Dr Fabricio Ferreira de Oliveira

  150. 2012 Annual Meeting Sunday, October 7, 2012 Poster Session Abstracts

    Article • Annals of Neurology, January 2012, Wiley

    Dr Fabricio Ferreira de Oliveira

  151. A topographic study on the evaluation of speech and language in the acute phase of a first stroke

    Article • Arquivos de Neuro-Psiquiatria, October 2011, FapUNIFESP (SciELO)

    Dr Fabricio Ferreira de Oliveira

  152. P1‐453: Functional independence and tests of cognitive assessment in patients with Alzheimer's disease

    Article • Alzheimer s & Dementia, July 2011, Wiley

    Dr Fabricio Ferreira de Oliveira

  153. P2‐153: Impact of cardiovascular risk factors over age of Alzheimer's disease onset in patients with low schooling

    Article • Alzheimer s & Dementia, July 2011, Wiley

    Dr Fabricio Ferreira de Oliveira

  154. P3‐260: Impact of schooling and cardiovascular risk factors over the rate of progression of Alzheimer's disease

    Article • Alzheimer s & Dementia, July 2011, Wiley

    Dr Fabricio Ferreira de Oliveira

  155. Twenty-first Meeting of the European Neurological Society 28–31 May, 2011

    Article • Deutsche Zeitschrift für Nervenheilkunde, April 2011, Springer Science + Business Media

    Dr Fabricio Ferreira de Oliveira

  156. Global aphasia as a predictor of mortality in the acute phase of a first stroke

    Article • Arquivos de Neuro-Psiquiatria, January 2011, FapUNIFESP (SciELO)

    Dr Fabricio Ferreira de Oliveira

  157. Semantic aphasia as a sole manifestation of acute stroke

    Article • Arquivos de Neuro-Psiquiatria, December 2010, FapUNIFESP (SciELO)

    Dr Fabricio Ferreira de Oliveira

  158. Preliminary topographic diagnosis of ischemic brain injuries according to speech and language disorders

    Article • Arquivos de Neuro-Psiquiatria, September 2009, FapUNIFESP (SciELO)

    Dr Fabricio Ferreira de Oliveira

  159. Short-term prognosis for speech and language in first stroke patients

    Article • Arquivos de Neuro-Psiquiatria, September 2009, FapUNIFESP (SciELO)

    Dr Fabricio Ferreira de Oliveira

  160. Hypoglossal nerve palsy as the sole manifestation of spontaneous internal carotid artery dissection

    Article • Arquivos de Neuro-Psiquiatria, March 2009, FapUNIFESP (SciELO)

    Dr Fabricio Ferreira de Oliveira

  161. Author Index

    Article • International Journal of Stroke, September 2008, SAGE Publications

    Dr Fabricio Ferreira de Oliveira

  162. Abstracts

    Article • International Journal of Stroke, September 2008, SAGE Publications

    Dr Fabricio Ferreira de Oliveira

  163. 0661 Primitive Neuroectodermal Tumor of the brain presenting with late spinal cord dissemination after surgical treatment and complementary radiotherapy and chemotherapy

    Article • Journal of the Neurological Sciences, January 2005, Elsevier

    Dr Fabricio Ferreira de Oliveira

  164. 1499 Trends on the use of complementary exams in modern day neurology: how to teach the patient about the tools actually needed for the investigation without conflicting knowledge with popular wisdom

    Article • Journal of the Neurological Sciences, January 2005, Elsevier

    Dr Fabricio Ferreira de Oliveira